Analysis of serum CA125 and related influencing factors in silicosis patients with pulmonary heart disease.
10.3760/cma.j.cn121094-20211115-00563
- Author:
Ye CHEN
1
;
Lei TU
2
;
Ling JIANG
3
;
Hui Xia JI
1
Author Information
1. Department of Occupational Diseases, Nanjing Occupational Disease Prevention and Control Hospital, Nanjing 210042, China.
2. Department of Pharmacy, Nanjing Occupational Disease Prevention and Control Hospital, Nanjing 210042, China.
3. Laboratory of Nanjing Occupational Disease Prevention and Control Hospital, Nanjing 210042, China.
- Publication Type:Journal Article
- Keywords:
Carbohydrate antigen 125, CA125;
Pulmonary heart disease;
Retrospective studies;
Silicosis
- MeSH:
Humans;
Male;
Pulmonary Heart Disease;
Blood Glucose;
Uric Acid;
Silicosis/complications*;
Risk Factors
- From:
Chinese Journal of Industrial Hygiene and Occupational Diseases
2023;41(3):209-212
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To analyze the serum carbohydrate antigen 125 (CA125) level and its influencing factors in male silicosis patients with pulmonary heart disease. Methods: In October 2021, data of 38 male patients with simple silicosis (silicosis group), 28 cases of silicosis with pulmonary heart disease (pulmonary heart disease group), and 27 healthy controls (control group) in the same age group were collected in inpatient and outpatient of Nanjing Occupational Disease Prevention and Control Hospital from January 2017 to December 2020. The serum CA125 levels of the three groups were compared, and the correlation between disease-related indexes and serum CA125 in silicosis patients with pulmonary heart disease was analyzed, as well as the influencing factors of pulmonary heart disease and serum CA125 levels in silicosis patients. Results: The serum CA125 level[ (19.95±7.52) IU/ml] in pulmonary heart disease group was higher than that in silicosis group[ (12.98±6.35) IU/ml] and control group[ (9.17±5.32) IU/ml] (P<0.05). There was no significant difference in serum CA125 level between the silicosis group and the control group (P>0.05). Serum CA125 levels were positively correlated with blood uric acid and fasting blood glucose in silicosis patients with pulmonary heart disease (r=0.39, 0.46, P<0.05). Serum CA125 level was a risk factor for silicosis patients with pulmonary heart disease (OR=1.13, 95%CI: 1.02-1.24, P<0.05). Dust exposure time, lactate dehydrogenase and smoking history were positively correlated with serum CA125 level in silicosis patients (P<0.05) . Conclusion: The serum CA125 level of male silicosis patients with pulmonary heart disease is significantly increased, and the level of CA125 is correlated with the level of fasting blood glucose and blood uric acid.
